Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic Syndrome
Clinical trial NCT03205995 · TERMINATED
Trial details
- NCT number
- NCT03205995
- Sponsor
- Omeros Corporation
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-02
- Primary completion
- 2021-02-02
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.